Krüppel-Like Factors in Vascular Inflammation: Mechanistic Insights and Therapeutic Potential

David R Sweet1,2, Liyan Fan1,2, Paishiun N Hsieh1,2

  • 1Case Cardiovascular Research Institute, Case Western Reserve University, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.

Insights

Krüppel-like factors (KLFs) regulate vascular inflammation, impacting cardiovascular diseases like atherosclerosis and stroke. Understanding KLF networks offers new therapeutic targets for vascular conditions.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Biology

Background:

  • Vascular inflammation, involving immune cells and vessel wall components, drives pathological remodeling.
  • This inflammation contributes to atherothrombotic diseases, including myocardial infarction, stroke, and critical limb ischemia.
  • Signaling pathways in vascular inflammation dictate transcriptional changes affecting cellular functions.

Purpose of the Study:

  • To review the role of Krüppel-like factors (KLFs) in vascular inflammation.
  • To explore how KLFs coordinate protective and detrimental responses in vascular inflammation.
  • To discuss the potential of targeting KLFs for cardiovascular disease therapies.

Main Methods:

  • This review synthesizes existing literature on KLFs in vascular inflammation.
  • It examines the functions of KLFs in both homeostatic and diseased vascular states.
  • The review focuses on transcriptional networks regulated by KLFs.

Main Results:

  • KLFs are central transcription factors regulating vascular biology.
  • KLFs exhibit diverse functions in cells involved in vascular inflammation.
  • Understanding KLF networks is crucial for elucidating disease pathogenesis.

Conclusions:

  • KLFs play a critical role in orchestrating vascular inflammation.
  • Targeting KLFs presents a promising avenue for future cardiovascular disease treatments.
  • Further research into KLF transcriptional networks will advance understanding and therapy for vascular diseases.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
62.4K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
255
Seedless Vascular Plants03:24

Seedless Vascular Plants

Seedless Vascular Plants Were the First Tall Plants on Earth
67.9K
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
389
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K